MARKET

GWPH

GWPH

GW Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

84.79
+2.99
+3.66%
Opening 11:53 04/06 EDT
OPEN
85.00
PREV CLOSE
81.80
HIGH
85.49
LOW
84.21
VOLUME
204.28K
TURNOVER
--
52 WEEK HIGH
196.00
52 WEEK LOW
67.98
MARKET CAP
2.62B
P/E (TTM)
-252.3512
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GWPH stock price target is 188.69 with a high estimate of 253.00 and a low estimate of 120.00.

EPS

GWPH News

More
  • GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEX® (cannabidiol) Oral Solution Has Been Descheduled And Is No Longer A Controlled Substance
  • GlobeNewswire · 1h ago
  • GW Pharma's Epidiolex descheduled by DEA
  • Seeking Alpha - Article · 2h ago
  • GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEX® (cannabidiol) in the Treatment of Seizures Associated with Tuberous Sclerosis Complex
  • GlobeNewswire · 6d ago
  • FDA accepts GW Pharma application for expanded use of Epidiolex
  • Seeking Alpha - Article · 6d ago

Industry

Biotechnology & Medical Research
+3.95%
Pharmaceuticals & Medical Research
+3.20%

Hot Stocks

Symbol
Price
%Change

About GWPH

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.
More

Webull offers kinds of GW Pharmaceuticals PLC- ADR stock information, including NASDAQ:GWPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GWPH stock news, and many more online research tools to help you make informed decisions.